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Hyperpolarized 83Kr surface quadrupolar relaxation (SQUARE) generates
MRI contrast that was previously shown to correlate with surface-to-volume
ratios in porous model surface systems. The underlying physics of SQUARE
contrast is conceptually different from any other current MRI methodology
as the method uses the nuclear electric properties of the spin I ¼ 9/2 isotope
83Kr. To explore the usage of this non-radioactive isotope for pulmonary
pathophysiology, MRI SQUARE contrast was acquired in excised rat lungs
obtained from an elastase-induced model of emphysema. A significant
83Kr T1 relaxation time increase in the SQUARE contrast was found in the
elastase-treated lungs compared with the baseline data from control lungs.
The SQUARE contrast suggests a reduction in pulmonary surface-to-volume
ratio in the emphysema model that was validated by histology. The finding
supports usage of 83Kr SQUARE as a new biomarker for surface-to-volume
ratio changes in emphysema.1. Introduction
Hyperpolarized krypton-83 (hp 83Kr) enablesMRI contrast that is indicative of sur-
face composition [1,2] and the surface-to-volume ratio (S/V) [3] in porous media.
TheT1-weightedMRI contrast is generated throughsurfacequadrupolar relaxation
(SQUARE) that causesS/V-dependent reduction in thehp83KrMRsignal intensity
as sketched in figure 1. Pulmonary SQUAREMRI contrast betweenmajor pulmon-
ary airways and the alveolar regions has recently been demonstrated in excised rat
lungs [4]. In this publication, the potential of hp 83Kr SQUARE contrast for lung
pathophysiology is evaluated using ex vivo MRI of an established rat model of
emphysema. The emphysema model was selected for this proof of concept study
because of the well-known deterioration of the alveolar surface that is expected
to cause increased SQUARE T1 times. Following the MRI acquisition, the alveolar
surface deterioration can be quantified through histology.
Emphysema is a component of chronic obstructive pulmonary disease
(COPD), the fourth leading cause of death worldwide [5]. The development of
emphysema is mainly linked to cigarette smoking with a smaller proportion
attributed to pollution, occupational exposure or intrinsic factors [6]. Over time,
there is significant alveolar destruction with the resulting reduction in surface
area for gas exchange with an accompanied loss of lung elasticity. Unfortunately,
current routine investigations such as lung function tests often fail to diagnose the
disease until the later stages [7] once a significant amount of damage has been
done. There is therefore a need for new biomarkers to detect the disease in the
early stages and to help separate COPD phenotypes [8].
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Figure 1. Illustration of the concept of hp 83Kr SQUARE contrast. The 83Kr atoms are depicted with the 10 possible spin states of this nuclear spin I ¼ 9/2 isotope
and with a non-spherical nucleus that possesses a nuclear electric quadrupolar moment. Hyperpolarized 83Kr atoms, drawn in blue, are depicted as occupying the
lowest spin state (i.e. corresponding to the highest MRI signal intensity). However, longitudinal T1 relaxation will cause the spins to assume other states (atoms
indicated in red), thus reducing the MRI signal intensity. Quadrupolar relaxation occurs when the electron cloud of 83Kr is forced out of the spherical shape.
(a) In the bulk gas phase a non-spherical symmetry is caused by collisions (i) leading to the gas phase signal decay within minutes. (b) When surfaces are present,
surface adsorption (ii) and possibly dissolution into deeper surface regions (iii) will lead to surface quadrupolar relaxation (SQUARE). Rapid exchange causes transfer
of the SQUARE effect into the gas phase where the rapid signal decay is observed with typical T1 times approximately 1 s in rat lungs. See Material and methods
section for further details.
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developed over the past decade with human studies using
both computed tomography (CT) [9] and magnetic resonance
imaging (MRI)-based techniques [10,11]. Hyperpolarized
noble gas MRI [12–14] using 3He and 129Xe is able to provide
measurements of ventilation and is able to delineate poorly ven-
tilated and non-functioning lung regions [11,12]. Recently,
visualization of delayed collateral ventilation into lung regions
has been performed [15], providing information complementary
to CT-based techniques. Furthermore, hp 3He and hp 129Xe pro-
vide measurements of the lung microstructure through the
apparent diffusion coefficient (ADC) [16–24]. Using animal
models of emphysema, the distinction between healthy and
emphysematous tissue was possible through fractional venti-
lation generated hp 3He MRI contrast before an increase in
alveolar diameter could be determined through histology
[25,26]. Unlike fractional ventilation that is decreased in the dis-
easemodel, ADCwas found to be increased in long-termdisease
models developed over a six-month period [21]. A very promis-
ingnewpulmonaryMRI contrast canbe obtainedbyprobing the
dissolved phase of hp 129Xe. A host of innovative new tech-
niques, such as xenon polarization transfer contrast (XTC)
[23,27–30], xenon alveolar capillary transfer (XACT) [31] and
chemical shift saturation recovery spectroscopy (CSSR)
[29,32,33] enable selective detection of gas phase xenon, tissueand plasma (TP) dissolved xenon and xenon interacting with
red blood cells (RBC). For example, Dregely et al. [23] found
a strong correlation between the XTC-based parameter
(MXTC-F) and CT data. Using CSSR spectroscopy, Patz et al.
[33] found a dramatic decrease in S/V in emphysema patients,
while alveolar septal thickness and capillary transit time was
not affected. In general, the findings suggest that a sensitive
probe for S/V changes is the key to early emphysema diagnosis.
This work sets forth the verification of a new type of hyper-
polarized noble gas modality for pulmonary studies, i.e. hp
83Kr SQUARE MRI contrast [4], which may provide a signifi-
cant addition to existing methodology. Previous work
exploring the underlying conceptual physics found SQUARE
to be the dominant cause of 83Kr T1 relaxation observed in
the gas phase in high S/V porous media such as lungs. See
figure 1 and Material and methods section for an explanation
of the SQUARE concept. The purpose of this work is to deter-
mine whether the SQUARE effect is sensitive enough to serve
as a probe for disease-related lung physiological changes.
The potential significance of SQUAREMRI contrast is that
it may enable a novel type of biomarker for pulmonary patho-
physiology through a fundamentally different physical effect
compared with those used in other pulmonary diagnostic
techniques such as hp 3He ADC and hp 129Xe dissolved
phase measurements. For example, the associated timescale
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that of ADC measurements. The nature of the contrast gener-
ation may provide a methodology sensitive not only to S/V
but also to the chemical composition of the surface. Further-
more, in model surfaces quadrupolar noble gas (i.e. 131Xe)
relaxation was affected by microscopic surface fine structure
[34,35]. Similarly, 83Kr SQUARE is likely to be sensitive to sur-
face corrugation and may, therefore, provide different S/V
values compared with dissolved xenon-based techniques [33].
Informed by the surface studies of previous models
[1–3,36,37], the underlying hypothesis of this publica-
tion is that hp 83Kr SQUARE MRI contrast can serve as a
biomarker for the alveolar S/V reduction caused by emphy-
sema. Confirmation of the S/V hypothesis in a preclinical
small animal model is a crucial milestone for the develop-
ment of hp 83Kr MRI. The intratracheal elastase exposure of
rat lungs to porcine pancreatic elastase (PPE) generates an
established model of emphysema whereby initial inflam-
mation is produced with the subsequent development of
airspace enlargement and destruction [38–41]. The exper-
imentally and regulatory less demanding ex vivo set-up
[14,42] was used for the MRI measurements in this proof of
concept work to set the basis for future in vivo preclinical
and clinical studies.2. Material and methods
2.1. SQUARE contrast
Figure 1 illustrates the mechanism of SQUARE with the nuclear
spin I ¼ 9/2 isotope 83Kr. Atomic nuclei are positively charged
electric monopoles, however, the nucleus of any spin I . 1/2 iso-
topes is non-spherical leading to a non-uniform nuclear electric
charge distribution. The resulting nuclear electric quadrupole
moment can interact with the surrounding electrons if the
noble gas atom is ‘distorted’—i.e. if the electronic cloud assumes
a non-spherical symmetry. In the bulk gas phase, far away from
surfaces (figure 1a), collisions events with other atoms cause
rapidly fluctuating electron cloud distortions that results in
83Kr quadrupolar relaxation with T1 times of several minutes at
ambient pressure. SQUARE (figure 1b) occurs when surface
adsorption and possibly dissolution into deeper surface regions
takes place. SQUARE can typically not be observed directly
owing to strong line broadening and the limited number of
atoms at the surface at any given time. However, the SQUARE
effect is transferred into the gas phase through rapid exchange
and, depending on the S/V ratio, can tremendously accelerate
the decay of the hp gas phase signal. SQUARE contrast is, there-
fore, potentially sensitive to S/V, surface composition and
surface temperature. SQUARE caused by high S/V alveolar
region of rat lungs reduces the gas phase T1 time to approxi-
mately 1 s leading to the rapid hp 83Kr signal decay in the
series of small flip angle spectra in figure 1b.
2.2. 83Kr Spin exchange optical pumping, compression
and transfer
Hyperpolarized 83Kr was produced in batch mode by SEOP as
described previously described in detail [43]. All MRI was
performed using enriched 83Kr (99.925% 83Kr, CHEMGAS,
Boulogne, France) to improve the available signal intensity.
A 15% krypton 85% N2 (99.999% purity, Air Liquide, Coleshill,
UK) mixture was used to reduce the consumption of expensive
isotopically enriched 83Kr. SEOP build-up times of 12 min, corre-
sponding to greater than 92% of the steady-state polarizationwere used to reduce the experimental duration. The hyper-
polarized gas extraction unit described previously [4,44]
was used to allow for below ambient pressure SEOP [4,43]
performed at 55–65 kPa [43]. Overall, the method produced
a 83Kr nuclear spin polarization of P ¼ 16–17% after accounting
for depolarization occurring in the gas extraction process
[44]. An approximate volume of 12–16 ml of the hp gas mixture
(1 : 6.7 Kr:N2) was obtained for lung imaging every 12 min. Since no
viablemethod currently exist to separate hp 83Kr from themixture, it
is instructional to report the apparent spin polarization of approxi-
mately Papp¼ 2.5%. The apparent polarization is the nuclear spin
polarization P times the fraction of krypton in the hp gas mixture
[43]. A discussion of the nuclear spin polarization P for isotopes
with nuclear spin I. 1/2 can be found in [45].
2.3. Hyperpolarized gas inhalation
The lungs were suspended in a 5% glucose solution (weight/
volume) in the ventilation chamber as described in previous
work [14,42]. The chamber was then placed in the centre of the
superconducting magnet bore with the temperature kept con-
stant at 295 K throughout the experiments. Active inflation of
the lung was accomplished by pulling to a ventilation syringe
volume (Vs) of 8 ml. Corresponding inhaled volumes (Vi) were
measured separately using the water displacement technique
on gas exhalation [14] and are shown in table 1. To limit gas trap-
ping (particularly notable in the PPE-treated lungs) the ex vivo
lungs were deflated over 30–60 s from Vs ¼ 8 ml to maximum
exhalation (Vs ¼ 0 ml) as has been reported elsewhere [46,47]
before hp 83Kr inhalation.
2.4. Magnetic resonance imaging protocol
MRI experiments were performed using a vertical bore 9.4 T
Bruker Avance III microimaging system (Bruker Corporation,
Billerica, MA, USA) with a standard Bruker double saddle coil
tuned to 83Kr resonance frequency of 15.40 MHz. The internal
diameter (ID) of the coil was 30 mm.
Coronal images were acquired into 64  32 matrices using
a variable flip angle (VFA) FLASH protocol (TE ¼ 1.8 ms,
TR ¼ 12.6 ms) [48]. Rectangular RF pulses of constant duration
of 0.3 ms and variable power levels were used in all experiments.
The imaging protocol had a total acquisition time 0.405 s to
minimize the effects of unwanted T1 decay during acquisition.
To obtain T1-weighted images [4], each imaging sequence was
started after a programmed time delay, td, post inhalation. Typi-
cally, td ¼ 0.2 s, 0.7 s, 1.2 s, 1.7 s and 2.2 s were used, although
some of the T1 maps were calculated from a series of four
images with td ¼ 0.5 s, 1.0 s, 1.5 s and 2.0 s. The inhalation itself
was accomplished manually by reducing the pressure in the
artificial pleural cavity using the ventilation syringe [14,42].
Slight alternations in the timing of the manual inhalation pro-
cedure (approx.+0.2 s) were deemed acceptable. In all imaging
experiments each individual image was acquired from a single
inhalation cycle using one VFA FLASH acquisition and no
signal averaging. The resulting FOV was 50.9  40.7 mm2.
2.5. Image reconstruction and T1 analysis
The raw 32 32 datasets were apodized using sine-bell squared
function and zero filled to 64 points in each spatial domain
before Fourier transformation. Final image resolution was
0.795  0.635 mm2 in the frequency encoding (longitudinal) and
in the phase encoding (transverse) directions, respectively. These
final 64 64 magnitude images were exported to IGOR Pro
(v. 6.01, Wavemetrics, Lake Oswego, OR, USA) for T1 analysis.
The T1 datasets were created for each series of images by
combining the images acquired at the individual time delays td
into a three-dimensional dataset where the first image in
Table 1. Demographic data from satellite subjects (histology only) and those used for hp 83Kr imaging (with subsequent histology). Summary of rat weights, whole
lung mean alveolar area+ standard deviation of the mean, inhaled volumes (Vi)+ standard deviation corresponding to inﬂation (syringe) volume Vs ¼ 8 ml with
associated inhalation pressures+ standard deviation. No values for Vi were determined in the histology groups. Values omitted were not measured.
lung usage
identiﬁer
rat weight
(g)
whole lung MAA
(104 mm2)
MRI: hp 83Kr MRI including histology,
Histology: (satellite group)
inhaled volume in
MRI, Vi (ml)
control CL.1 492 — MRI 7.0+ 0.3
CL.2 555 2.5+ 0.1 MRI 6.8+ 0.1
CL.3 499 3.7+ 0.6 MRI 6.8+ 0.1
CL.4 400 1.9+ 0.1 histology N/A
CL.5 412 2.5+ 0.4 histology N/A
elastase (PPE)
treated
EL.1 390 6.3+ 1.1 MRI 5.9+ 0.7
EL.2 508 6.8+ 1.1 MRI 6.1+ 0.6
EL.3 416 5.1+ 1.0 MRI 6.9+ 0.3
EL.4 440 4.5+ 0.6 MRI 7.3+ 0.4
EL.5 513 3.6+ 1.0 MRI 6.1+ 0.2
EL.6 382 4.8+ 1.4 histology N/A
EL.7 436 10.8+ 6.2 histology N/A
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time delay, td as described in [4]. The T1 values outside of the
0 s , T1  6 s range were rejected as physically not meaningful.
The T1 values within the range of 0 s , T1  6 s but located out-
side the lung contour region, or the region of interest (ROI), were
also discarded. The ROI was determined from the first image
in each T1 set. These final T1 maps were used to produce T1
histograms for each lung reported in this study.
The T1 data collected from the ROI in each T1 map were
binned into 200 intervals with 0.03 s increment. The resulting his-
tograms were analysed using build-in Multipeak 1.4 fitting
procedure and automated peak picking. A bi-modal Gaussian
distribution of T1 values in the lung was assumed because of
the distinct alveolar and conducting airway compartments pre-
sent in the lung. The results of the analysis returned the most
probable (expected value, EV) relaxation time, TEV1 , its prob-
ability and distribution measured as full width, half maximum,
FWHM(T1) for each of the two Gaussian components.2.6. Model characterization: the elastase model
and preparation for ex vivo MRI
Male Sprague-Dawley rats (260–300 g) were purchased from
Harlan UK Ltd. (Bicester, UK). Home Office guidelines for
animal welfare based on the Animals (Scientific Procedures) Act
1986 were strictly observed. Experimental emphysema was
induced by instilling one dose of 120 U kg21 PPE (Merck Chemi-
cals Ltd, Nottingham, UK) intratracheally at 1 ml kg21 directly
into the airways under general anaesthesia (inhaled isofluorane
4% with medical grade oxygen for 3–4 min) [40,49]. Control ani-
mals were similarly treated with 1 ml kg21 sterile saline
(Fresenius Kabi Ltd, Manor Park, UK) at the same time. At 28
days after intratracheal dosing animals were weighed and eutha-
nized by overdose of sodium pentobarbital 200 mg kg21
intra-peritoneal (Merial Animal Health, Harlow, UK). After con-
firmation of death, a catheter was inserted into the caudal vena
cava to allow flushing of the pulmonary circulation with 20 ml
heparin 100 IU ml21 (Wockhardt UK Ltd, Wrexham, UK) in
0.9% saline solution (Baxter Healthcare Ltd, Thetford, UK)followed by 20 ml21 Dublecco’s phosphate buffer solution
(D-PBS, Sigma-Aldrich Ltd, Gillingham, UK) to remove residual
blood from the pulmonary circulation. The heart and lungs were
subsequently removed en masse.
Lungs for ex vivo hp 83Kr imaging had a polytetrafluor-
ethylene (PTFE) adapter tube inserted into the trachea
5–10 mm above the carina and sutured into place. The heart
and lungs were then suspended in 5% glucose solution
(weight/volume) (Baxter Healthcare Ltd, Thetford, UK) with
the trachea pointing downwards as has previously reported
[14,42]. The ex vivo lungs were repeatedly inflated with 8–10
ml of room air to check for gas leaks either from the suture
around the trachea or the lungs themselves. The lungs were
chilled to 278 K for transportation to the imaging facility
during which time they were repeatedly inflated with 8–10 ml
of air at 30–60 min intervals. Time from lung harvest to the
start of imaging was no more than 8 h for each lung.2.7. Model characterization: alveolar cross-section
measurements
PPE-induced changes in air space were measured in both a satel-
lite group of rats and on the ex vivo lungs used for hp 83Kr MRI.
Lungs from both groups were similarly prepared by inflating to
forced vital capacity (25 cm H2O) with 5% formalin–saline sol-
ution (Sigma-Aldrich Ltd, Gillingham, UK). The trachea was
then tied off and the lungs and heart removed en bloc and
placed in formalin. After at least 24 h in formalin, an experienced
histologist processed the lungs. Sections were cut from the wax
embedded samples using a microtome and stained with H&E.
Experimental emphysema was assessed by measuring aver-
age air space area using a method describe by Belloni et al. [50]
and used previously [40]. Briefly, computer-assisted image
analysis was performed using an Olympus BX40 microscope
and Zeiss image-processing software (Imaging Associates,
Bicester, UK). Using colour thresholding techniques, the total
alveolar air space area and the number of air spaces was
measured from five random fields per sample. From these
figures the mean air space area was calculated. Any fields
0.7 s 1.2 s 1.7 s 2.2 s
0.2 s 0.7 s 1.2 s 1.7 s 2.2 s
T1 map
T1 map 5 mm5 mm
td = 0.2 s
0 s
1 s
2 s
3 s
4 s
T1
(a) (b)
(d)(c)
Figure 2. Series of hp 83Kr MR images with resultant T1 maps in control and PPE-treated lungs. Each image was acquired using a new delivery of hp
83Kr. (a) VFA
FLASH MRI with no slice selection in control lung CL.2, using a variable relaxation delay, td, ranging from 0.2 to 2.2 s between hp gas inhalation and acquisition as
indicated in the figure. Note that the major airways are less affected than the lung parenchyma by increasing td values. (b) The resultant SQUARE T1 map for the
control lung displays longer T1 values (green) for the major airways and shorter values for the alveolar region (blue). (c) VFA FLASH MRI as in (a) for the PPE-treated
lung EL.1. The lung exhibits heterogeneity in ventilation that is likely caused by the PPE treatment but is not a clear indicator for emphysema. (d ) The resultant
SQUARE T1 map of the PPE-treated lung displays prolonged relaxation times (green) in the alveolar area compared with the control SQUARE T1 map above.
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assessing the slides was blinded to the treatment. Details of con-
trol and PPE-treated lungs are shown in table 1 with average
measurements of mean alveolar area (MAA) in the satellite
group and in those lungs processed post ex vivo hp 83Kr MRI.3. Results
3.1. Comparison hyperpolarized 83Kr magnetic
resonance images and resultant T1 maps between
control and porcine pancreatic elastase-treated
groups
Examples of hp 83Kr MR images acquired using the series of
increasing delay times, td, and the resultant SQUARE T1
maps are displayed in figure 2. Compared with the control
lungs, a significant heterogeneity of ventilation was found
for in the PPE-treated lung. However, heterogeneous venti-
lation is not particular to emphysema as it can be caused
by a variety of diseases and effects. For example, hetero-
geneous ventilation was also observed in two of the ex vivo
control lungs shown in figure 3. Furthermore, ventilation
MRI with a better image resolution can be obtained through
hp 3He or hp 129Xe and the focus of this work was on T1
relaxation generated contrast. The hp 83Kr MR images
in figure 2a demonstrate how increasing td delay time
between inhalation and image acquisition (i.e. from 0.2 s to
2.2 s) leads to a decrease in hp 83Kr signal intensity due to
T1 relaxation. As sketched in figure 1a, the
83Kr gas phase
relaxation outside the lung is in the order of minutes [51].
The fast 83Kr T1 relaxation found within the lung is therefore
predominantly caused by interactions of the krypton
atoms with the surrounding surface—i.e. by the SQUARE
effect. Note ‘surface’ does not necessarily refer solely to
the outermost surfactant layer and deeper levels, includingcell membranes, may contribute as long as fast exchange
transfers the depolarized 83Kr back into the alveolar gas
phase where MRI signal detection takes place (only gas
phase 83Kr signals are MR observable—see also figure 1). In
any case however, the 83Kr relaxation time is expected to be
sensitive to the S/V ratio and the purpose of this study is
to investigate whether SQUARE can serve as an indicator
for the emphysema model.
Although other factors, such as chemical composition
affect SQUARE [3] the expected strong dependence on S/V
ratios is the likely cause for regions with lower S/V, such
as the major airways in the control lung, to experience a
slower T1 relaxation and thus a slower depolarization rate.
These areas remain ‘bright’ in the MR images while areas
with higher S/V lead to ‘dark’ regions of faster depolariz-
ation. The T1 map calculated from the delay time
td-dependent signal decay leads to the actual SQUARE con-
trast images shown in figure 2b for the control lung and
figure 2d for the elastase-treated lung. Prolonged relaxation
times were found for the major airways compared with
the alveolar region in the control lung in figure 2b (see also
ref. [4]). PPE-treated lungs, serving as a model for emphy-
sema, are imaged for the first time with hp 83Kr in this
work. The hp 83Kr SQUARE T1 map of the lung shown in
figure 2d exhibits increased T1 values for the alveolar region
compared with control lungs. This is reflected in the
SQUARE T1 map that displays an elevated level of green
colour compared with figure 2b (far right).
Figure 3 depicts the T1 maps of all three control lungs. The
data from the T1 maps were used for histogram analysis with
frequencies of T1 values within 0.03 s intervals. The T1 relax-
ation time distribution of the histograms was analysed using
bimodal Gaussian distribution function. The four character-
istic T1 times from this fitting—i.e. the most probable
(expected value, EV) relaxation time, TEV1 , of each of the
two Gaussian components and their distribution measured
as full width, half maximum, FWHM(T1), are listed in
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Figure 3. 83Kr MRI T1 maps (SQUARE contrast) of three control lungs and their corresponding histograms. The SQUARE T1 maps have been obtained as described in
figure 2. Blue colours in the alveolar regions indicate short T1 values around 1 s. The histograms depict the frequencies (i.e. pixel count from the SQUARE T1 maps) of
T1 values within 0.03 s intervals. Bimodal fitting leads to a narrow distribution of fast relaxing pixels centred around T
EV(f )
1  1 s (black dotted line—displayed with
negative pixel count offset for clarity) and a broader distribution centred around T EV(f )1  1:3 s (green dashed line -negative pixel count axis offset). The solid black
line displays the sum of the two Gaussian distributions. The characteristic T1 times are explained in insert in histogram (c) and the specific values for each lung and
averaged data are listed in table 2 with lung CL.1 shown in (a), CL.2 in (b) and CL.3 in (c).
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ponent centred around TEV(f)1 is indicated by a black dotted
line in the histograms, whereas the slow relaxing group,
centred around TEV(sl)1 , is displayed by the green dashed
Gaussian curve. The sum of both components results in the
black solid line that very closely resembles the histograms,
suggesting that bimodal fitting is a good approach for extrac-
tion of parameters that are characteristic for the SQUARE
behaviour of a lung.
Figure 4 shows the SQUARE T1 maps and histograms for
PPE-treated lungs. SQUARE T1 maps and histograms displaymarked differences between PPE-treated and control lungs as
can also be noted by the characteristic T1 times from the
bimodal fitting listed in table 2. The combined histograms
for all three control lungs are shown together with the com-
bined histograms of the four elastase-treated lungs in figure 5.
Figure 6 displays a fifth lung (EL.5) from the PPE group
that exhibits SQUARE characteristics very similar to that of
control lungs. However, table 1 shows that the averaged
MAA is fairly low with MAA ¼ 3.6  104mm and thus is
similar to that of the control group. The regional (lobar)
MAA values are shown in figure 6c together with the
Table 2. Characteristic T1 times from bimodal ﬁtting of the histograms of all lungs used in this work.
T EV(f )1 (s) FWHM(T
(f )
1 ) (s) T
EV(sl)
1 (s) FWHM(T
(sl)
1 ) (s)
rat identiﬁer mean mean mean mean
control lung CL.1 0.9958 0.19619 1.2353 0.53927
CL.2 1.0130 0.091234 1.2189 0.30050
CL.3 1.0099 0.14987 1.3556 0.48057
average+ standard deviation 1.00620+ 0.009 0.14576+ 0.053 1.2699+ 0.075 0.44011+ 0.124
combined histogram of control
lungs (ﬁgure 5, blue histogram)
1.0112 0.13073 1.2494 0.38797
elastase (PPE) treated lung EL.1 1.2559 0.12770 1.4787 0.32787
EL.2 1.2311 0.30498 1.7067 0.52674
EL.3 1.3697 0.28202 2.0474 0.63887
EL.4 1.1576 0.21975 1.5708 0.71203
average+ standard deviation 1.25358+ 0.088 0.23361+ 0.079 1.7009+ 0.249 0.55138+ 0.167
combined histogram of elastase (PPE)
treated lungs (ﬁgure 5, red histogram)
1.2734 0.28201 1.7288 0.54928
EL.5 0.94994 0.1333 1.2257 0.4500
rsif.royalsocietypublishing.org
J.R.Soc.Interface
12:20150192
7
 on December 9, 2015http://rsif.royalsocietypublishing.org/Downloaded from averaged MAA values from the control and elastase groups.
All lobes except for the left lung lobe of the lung display
values in line with the control group. The left lung lobe
exhibits increased MAA significantly above the average
from the PPE group.4. Discussion
Two of the control lungs in figure 3 display clear ventilation
heterogeneity as parts of the lungs remain dark in the hp 83Kr
MR images. The cause of the heterogeneity is unknown but
the lungs were transported over a 3-h period, subsequent to
excision, between the location of animal holding facility at
Imperial College and the hp MRI facility at Nottingham.
Nevertheless, the analysis of the SQUARE T1 maps and his-
tograms of all three control lungs led to comparable results
with similar bimodal T1 distribution. Figure 5 depicts the
combined T1 frequencies for the control group and for the
elastase-treated animal lungs. The characteristic T1 values
from bimodal fitting are listed in table 2 and show little vari-
ation within the two groups (i.e. control and PPE group). The
pronounced increase in the TEV1 times for the PPE group in
figure 5 and table 2 shows that the TEV1 data can serve as
an indicator for the development of the symptoms in the
emphysema model. Presumably, the TEV1 data are correlated
to MAA. This correlation is expected from previous work
with model surfaces but requires further corroboration in
future studies. In any case however, the FWHM(T1) data
are not associated with the MAA differences between
the two groups. This view is further supported by the
box diagrams in figure 7, which show no overlap in TEV1
data between the two groups. However, the associated
FWHM(T1) data almost completely overlap and are therefore
unlikely to be useful as a biomarker for changes in MAA
associated with the disease model.
Figure 7 also provides the results of statistical significance
testing using Student’s t-test at a critical significance level ofa ¼ 0.05. The null hypothesis, i.e. assuming no statistically
significant difference in TEV1 values between control and
PPE group, was rejected for TEV(f )1 and T
EV(sl)
1 but not for
FWHM(T(f)1 ) and FWHM(T
(sl)
1 ). This suggests that two par-
ameters, namely TEV(f )1 and T
EV(sl)
1 , are useful biomarkers for
the elastase model of emphysema and may be sensitive to
the increase in MAA.
A correlation between MAA and SQUARE would be
caused by the dependence on lung S/V ratio. A decreasing
S/V is expected from increasing MAA in the emphysema
model [21,26] and it is known from previous work with
model surfaces [3] that T1/ V/S. In this work, the T1
increase was not quantitatively correlated with the increase
in MAA but a statistically significant increase in TEV(f)1 and
TEV(sl)1 was observed for the emphysema model with
increased MAA in histology compared with the control
group. The bimodal appearance of the histogram could be
caused by the presence of high S/V in the alveolar region
and lower S/V within the airways. The alveoli may cause
the fast relaxing mode described by TEV(f)1 with a narrow
FWHM(T(f)1 ) as the alveolar region will be fairly homo-
geneous. The airways, on the other hand, may contribute to
the slow TEV(sl)1 mode with a broad distribution and hence a
larger FWHM(T(sl)1 ) due to the higher variability in S/V
within the various airway generations. Note the relative con-
tribution (in pixel count) between the two modes may not be
quantitative due to the different extent of depolarization
during the initial 0.2 s (fixed) delay and image acquisition.
If the slow mode is indeed (at least partially) caused by the
airways, the increase in TEV(sl)1 in the elastase-treated rat
lungs would suggest that the S/V in the airways is affected
by the disease model. Although this point was not further
investigated, nitrogen chaser hp 83Kr MRI could be used for
future exploration where the airways are largely purged
with a small volume of N2 at the end of the inhalation [42].
The fifth lung (EL.5) from the PPE-treated group was
excluded from the statistical analysis because the MAA
increase developed asymmetrically in the left lung lobe only,
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Figure 4. 83Kr MRI T1 maps (SQUARE contrast) of four of five PPE-treated lungs and their corresponding histograms. Green colours have now become more prevalent
in the alveolar regions indicating increased T1 values compared with those shown in figure 3. The histograms display the shift to larger T1 values with T
EV(f )
1  1:3 s
(black dotted line), T EV(f )1  1:7 s (green dashed line) with exact data listed in table 2. (a) Lung EL.1, (b) EL.2, (c) EL.3 and (d ) EL.4. As in figure 3, the fast relaxing
group has a narrower distribution than the slower relaxing group.
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in figure 6c one would expect T1 values similar to those from
control lungs in all lobes except for the left lung lobe that
exhibited very high MAA values. The SQUARE T1 map and
the corresponding histogram are indeed very similar to that
of the control lungs, however, this also includes the T1
values found in the left lobe. One would expect that the unex-
posed part of the lung to shows control lung behaviour, as
indeed observed, but one would also expect very long T1times from the left lobe. However, the left lobe may have
been damaged too excessively and some regions may, there-
fore, no longer be ventilated. These areas will not be able to
contribute to the SQUARE T1 map. Although non-ventilated
areas should appear as ‘dark’ regions in the hp 83Kr MR
images, these zones may be masked by MR signals from unaf-
fected regions that contribute to the non-slice selective images.
For this work, excised lungs have been used. Two of the
control lungs exhibited ventilation defects that may have been
p = 0.00517
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Figure 7. Box diagram of the characteristic data listed in table 2. The MRI
T EV(f )1 data between control and elastase (PPE) group do not overlap. The
same observation is made for the T EV(sl)1 data. In contrast, the distribution
of T1 values for the two modes of a histogram (characterized by
FWHM(T1)) significantly overlaps between control and PPE group, indicating
that no significant statistical difference to be expected from the T1 spread.
However, the variation in T EV1 , in particular T
EV(sl)
1 , between the individual ani-
mals is more pronounced in the PPE group than in the control animals as
visible in the added data in figure 5.
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between the laboratories. Although this situation is non-ideal,
the experiments demonstrate that the SQUARE T1 contrast
was little affected by any damage arising from lung excision,
ex vivo transport, and ex vivo experiments. The MAA, obtained
after MR image acquisition, were in the expected range for PPE
and control group, except for EL.5 as discussed above.
This work demonstrated that hp 83Kr SQUARE can serve
as a biomarker for the elastase model of emphysema, in all
likelihood because SQUARE senses changes in S/V. If the
absence of harmful X-ray radiation is a strong motivation to
explore the various pulmonary MRI techniques, a further
potential advantage arises with hp 83Kr: the SQUARE effect
can be used as a pulmonary biomarker without the presence
of pulsed magnetic field gradients (PFGs). Unlike ADC
measurements where PFGs are required to generate the MRI
contrast, SQUARE is solely caused by a relaxation rooted
physical effect. Although PFGs are still needed for the MR
image generation, hp 83Kr SQUARE may have a potential as
a global lung surface biomarker for pulmonary screeningwithout spatial resolution. Since the effect of relaxation can
be measured remotely [37], SQUARE may be observed with-
out an MRI scanner if the effect is remotely detected upon
exhalation into a small bench-top NMR device.
The study presented here was focused on providing a first
demonstration of hp 83Kr SQUARE usage as an MRI contrast
and biomarker for pulmonary pathophysiology in an animal
model. Remarkably, using completely different physical con-
cepts from those described here, krypton gas usage has been
previously reported for contrast generation in dual energy
computed tomography (DECT) [52]. The high-volume inhala-
tion of a mixture of 80% krypton and 20% O2 did not lead to
adverse effects in COPD patients. Compared with CT,
SQUARE MRI is expected to require lower krypton quantities
for usable contrast generation. Finally, molecular oxygen
does not dramatically accelerate 83Kr T1 relaxation and
SQUARE measurements in rodent lungs [42] were unaffected
by the presence of up to 40% O2.5. Conclusion
Informed by the previous S/V dependence of SQUARE in
model surfaces, the aim of this work was to demonstrate the
ability of hp 83Kr SQUARE MRI to serve as a biomarker for
the elastase model of emphysema. It was demonstrated that
two characteristic TEV1 times, obtained from bimodal fitting
of the histograms, enable statistically significant distinction
between emphysema model and control lung. Beyond
statistics, the difference between the control group and emphy-
sema model can also be identified from visual inspection of
the 83Kr SQUARE images shown in figures 3 and 4. The use
of the simpler ex vivo model has allowed for rapid confir-
mation of the imaging technique despite some ventilation
defects in the control group. Hp 83Kr SQUARE may serve as
a potential biomarker for pulmonary disease-related S/V
ratio changes. Future quantification of the effect and compari-
son with other hp noble gas modalities will provide further
evaluation of this technique. Because neither the application
of magnetic field gradients nor the detection within high mag-
netic fields is required for SQUARE measurements, this new
biomarker should also be explored for potential pulmonary
mass screening using small bench-top devices.
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